Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels

Published:2020-02-07 Issue:2 Volume:3 Page:e1920949
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Munk Nicolai E.¹,Knudsen Jakob S.¹,Pottegård Anton²,Witte Daniel R.³⁴⁵,Thomsen Reimar W.¹

Affiliation:

1. Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark

2. Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark

3. Department of Public Health, Aarhus University, Aarhus, Denmark

4. Danish Diabetes Academy, Odense, Denmark

5. Steno Diabetes Center Aarhus, Aarhus, Denmark

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2760444/munk_2020_oi_190784.pdf

Reference22 articles.

1. Understanding the gap between efficacy in randomized controlled trials and effectiveness in real-world use of GLP-1 RA and DPP-4 therapies in patients with type 2 diabetes.;Carls;Diabetes Care,2017

2. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies.;Sørensen;Hepatology,2006

3. Participation of patients 65 years of age or older in cancer clinical trials.;Lewis;J Clin Oncol,2003

4. External validity of randomised controlled trials: “to whom do the results of this trial apply?”;Rothwell;Lancet,2005

5. Management of hyperglycaemia in type 2 diabetes, 2018: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).;Davies;Diabetes Care,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action;Pharmacoepidemiology and Drug Safety;2024-08-30

2. Real-world effectiveness of intravitreal dexamethasone implants - Comparison between eyes eligible and ineligible for clinical trials and their associated outcomes;Biomedical Journal;2024-02

3. A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial;Clinical and Experimental Hypertension;2023-08-28

4. Real-world assessment of effectiveness and safety profile of remogliflozin etabonate in management of type 2 diabetes mellitus;International Journal of Diabetes in Developing Countries;2022-05-19

5. Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study;Diabetes Therapy;2022-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3